Drug Recovery in the Philippines: Governance, Research, and Practices

Deadline of Submission: April 11, 2021

Presentation Date: April 21, 2021

Rules for Submission

Please read the submission rules before submitting an abstract.

1. Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.

2. Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit

3. Presentation Type: Abstracts may be submitted for oral presentation.

4. The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation

5. The presenter will present their extended abstract via Zoom on April 21, 2021

6. Abstracts must be received by the announced deadline.

7. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

8. Abstracts must be submitted in English.

9. Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.

• Presenting author’s and co-authors’ (if any) contact details

  • Full first and family name(s)

  • Email address

  • Affiliation details: department, institution / hospital, city, state (if relevant), country

  • Phone number

• Abstract title – must be in UPPER CASE

• Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count

• Abstracts can be structured or unstructured (please include references)

  • For Structured abstract, it is recommended to follow this format:

    • Objectives

    • Methods

    • Results

    • Conclusions

    • References

• Accepted file types are .PDF, .doc, and .docx

• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.

• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.

• Submissions may not contain patient/client names, hospital ID numbers or other identifying information.

• You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.

• Please contact us (research@acdp.asia, cc: ma.sarahjane.lopez@gmail.com ) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.

• Please do not submit multiple copies of the same abstract.

Deadline of Submission: April 10, 2021

Presentation Date: April 28, 2021

Rules for Submission

Please read the submission rules before submitting an abstract.

10. Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.

11. Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit

12. Presentation Type: Abstracts may be submitted for oral presentation.

13. The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation

14. The presenter will present their extended abstract via Zoom on April 28, 2021

15. Abstracts must be received by the announced deadline.

16. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

17. Abstracts must be submitted in English.

18. Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.

• Presenting author’s and co-authors’ (if any) contact details

  • Full first and family name(s)

  • Email address

  • Affiliation details: department, institution / hospital, city, state (if relevant), country

  • Phone number

• Abstract title – must be in UPPER CASE

• Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count

• Abstracts can be structured or unstructured (please include references)

  • For Structured abstract, it is recommended to follow this format:

    • Objectives

    • Methods

    • Results

    • Conclusions

    • References

• Accepted file types are .PDF, .doc, and .docx

• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.

• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.

• Submissions may not contain patient/client names, hospital ID numbers or other identifying information.

• You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.

• Please contact us (research@acdp.asia, cc: ma.sarahjane.lopez@gmail.com ) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.

• Please do not submit multiple copies of the same abstract.

Deadline of Submission: April 15, 2021

Presentation Date: May 5, 2021

Rules for Submission

• Please read the submission rules before submitting an abstract.

• Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.

• Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit

• Presentation Type: Abstracts may be submitted for oral presentation.

• The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation

• The presenter will present their extended abstract via Zoom on May 5, 2021

• Abstracts must be received by the announced deadline.

• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

• Abstracts must be submitted in English.

• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.

​Before you begin, please prepare the following information:

• ​Presenting author’s and co-authors’ (if any) contact details

  • Full first and family name(s)

  • Email address

  • Affiliation details: department, institution / hospital, city, state (if relevant), country

  • Phone number

• Abstract title – must be in UPPER CASE

• Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count

• Abstracts can be structured or unstructured (please include references)

  • For Structured abstract, it is recommended to follow this format:

    • Objectives

    • Methods

    • Results

    • Conclusions

    • References

• Accepted file types are .PDF, .doc, and .docx

• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.

• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.

• Submissions may not contain patient/client names, hospital ID numbers or other identifying information.

• You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.

• Please contact us (research@acdp.asia, cc: ma.sarahjane.lopez@gmail.com ) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.

• Please do not submit multiple copies of the same abstract.

Deadline of Submission: April 18, 2021

Presentation Date: May 12, 2021

Rules for Submission

Please read the submission rules before submitting an abstract.

19. Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.

20. Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit

21. Presentation Type: Abstracts may be submitted for oral presentation.

22. The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation

23. The presenter will present their extended abstract via Zoom on May 12, 2021

24. Abstracts must be received by the announced deadline.

25. The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

26. Abstracts must be submitted in English.

27.Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.

​Before you begin, please prepare the following information:

• ​Presenting author’s and co-authors’ (if any) contact details

  • Full first and family name(s)

  • Email address

  • Affiliation details: department, institution / hospital, city, state (if relevant), country

  • Phone number

• Abstract title – must be in UPPER CASE

• Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count

• Abstracts can be structured or unstructured (please include references)

  • For Structured abstract, it is recommended to follow this format:

    • Objectives

    • Methods

    • Results

    • Conclusions

    • References

• Accepted file types are .PDF, .doc, and .docx

• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.

• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.

• Submissions may not contain patient/client names, hospital ID numbers or other identifying information.

• You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.

• Please contact us (research@acdp.asia) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.

• Please do not submit multiple copies of the same abstract.

Deadline of Submission: April 20, 2021

Presentation Date: May 19, 2021

Rules for Submission

Please read the submission rules before submitting an abstract.

• Abstract may include critical analysis, policy papers, empirical researches (quantitative and/or qualitative), systematic reviews, scoping reviews, metaanalysis, expert opinion lectures, editorials, and theoretical papers; whether published or not.

• Abstracts must be submitted via Google Form. Please submit at http://bit.ly/ACDPSubmit

• Presentation Type: Abstracts may be submitted for oral presentation.

• The ACDP secretariat scientific committee will determine whether the abstract will be accepted for presentation

• The presenter will present their extended abstract via Zoom on May 19, 2021

• Abstracts must be received by the announced deadline.

• The presenting author is required to ensure that all co-authors are aware of the content of the abstract and agree to its submission, before submitting the abstract.

• Abstracts must be submitted in English.

• Disclosure of Conflicts of Interest: Abstract submitters will be required to disclose any conflict of interests in the submission form.

Guidelines for Submission

Please read the submission guidelines before submitting an abstract.

​Before you begin, please prepare the following information:

• ​Presenting author’s and co-authors’ (if any) contact details

  • Full first and family name(s)

  • Email address

  • Affiliation details: department, institution / hospital, city, state (if relevant), country

  • Phone number

• Abstract title – must be in UPPER CASE

• Abstract text – limited to 1000 words excluding acknowledgements and references. Please note: word count

• Abstract topic– select the abstract topic:

  • Philippine Public Health Policy on Substance (Drug) Abuse and Recovery

    • E.g. Medical Marijuana, Harm Reduction

  • Philippine Public Health Practices on Substance (Drug) Abuse and Recovery

    • E.g. 12 steps facilitation, Group therapy, Behavioral therapy, Relapse Prevention, Pharmacological interventions

• Abstracts can be structured or unstructured (please include references)

  • For Structured abstract, it is recommended to follow this format:

    • Objectives

    • Methods

    • Results

    • Conclusions

    • References

• Accepted file types are .PDF, .doc, and .docx

• Use only standard abbreviations. Place special or unusual abbreviations in parentheses after the full word the first time it appears.

• Use generic names of drugs. The presentation must be balanced and contain no commercial promotional content.

• Submissions may not contain patient/client names, hospital ID numbers or other identifying information.

• You will receive an acknowledgement from the ACDP secretariat after you have submitted your abstract.

• Please contact us (research@acdp.asia, cc: rowalt.alibudbud@dlsu.edu.ph) if you have not received an acknowledgement after 5 working days that your abstract has been submitted.

• Please do not submit multiple copies of the same abstract.